Mozobil Plerixafor 24mg Injection

24mg/1.2ml Injection , Vial

4.5 (154)

₹10,000

Mozobil 24mg Injection is a hematopoietic stem cell mobilizer used in autologous stem cell transplantation for patients with certain cancers. It helps move stem cells from the bone marrow into the bloodstream, where they can be collected for transplantation after chemotherapy or radiation therapy. The injection is administered by a qualified healthcare professional, with the dosage based on the patient’s condition and treatment plan. Regular monitoring ensures safe and effective therapy while improving the success of stem cell collection.

Description

Introduction Of Mozobil 24mg Injection:

Mozobil 24mg Injection is a hematopoietic stem cell mobilizer used, in combination with filgrastim (G-CSF), to help release stem cells from the bone marrow into the bloodstream in patients with non-Hodgkin’s lymphoma and multiple myeloma undergoing autologous stem cell transplantation.

Mozobil 24mg Injection is administered only by a trained healthcare professional as a subcutaneous injection, approximately 11 hours before the start of apheresis (stem cell collection), following an initial course of G-CSF. Your doctor will decide the dose and duration of use based on your body weight, condition, and treatment plan. It should never be self-administered without medical supervision.

Diarrhea, nausea, and injection site reactions are among the most common effects of this medicine. Your doctor may advise regular blood tests to monitor your white blood cell and platelet counts during treatment. Inform your doctor immediately if you notice difficulty breathing, swelling of the face or throat, severe abdominal pain, or unusual bleeding.

Uses Of Mozobil 24mg Injection:

  • Stem cell mobilization in Non-Hodgkin’s Lymphoma
  • Stem cell mobilization in Multiple Myeloma

Benefits Of Mozobil 24mg Injection:

1. Non-Hodgkin’s Lymphoma

In patients with non-Hodgkin’s lymphoma preparing for autologous stem cell transplantation, Mozobil 24mg Injection helps mobilize a sufficient number of stem cells from the bone marrow into the blood, supporting successful collection and later engraftment after transplant.

2. Multiple Myeloma

Multiple myeloma is a cancer of plasma cells in the bone marrow. Mozobil 24mg Injection, used together with G-CSF, helps improve the number of stem cells collected for transplantation, supporting better outcomes during the transplant process.

Side effects of Mozobil 24mg Injection:

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Common side effects of Mozobil:

  • Diarrhea
  • Nausea
  • Vomiting
  • Constipation
  • Dry mouth
  • Injection site reactions
  • Dizziness
  • Fatigue

Machanism Of Action Of Mozobil 24mg Injection:

Mozobil Injection contains Plerixafor, a CXCR4 chemokine receptor antagonist. It works by blocking the CXCR4 receptor on stem cells, which normally helps keep them anchored within the bone marrow. By interrupting this signal, Mozobil allows stem cells to be released into the bloodstream, where they can be collected for transplantation.
Contact Us

Info Table
Packaging Size 1.2ml Vial
Composition PLERIXAFOR-24MG/1.2ML
Manufacturer/Marketer GENZYME & SANOFI COMPANY
Consume Type Parenteral
Treatment Non-Hodgkin’s Lymphoma, Multiple Myeloma (Stem Cell Mobilization)
Prescription/Non prescription Prescription
Form Injection (Single Use Vial)
Country of Origin Imported
Vendor Info
Benefits
Reviews

Description

Introduction Of Mozobil 24mg Injection:

Mozobil 24mg Injection is a hematopoietic stem cell mobilizer used, in combination with filgrastim (G-CSF), to help release stem cells from the bone marrow into the bloodstream in patients with non-Hodgkin’s lymphoma and multiple myeloma undergoing autologous stem cell transplantation.

Mozobil 24mg Injection is administered only by a trained healthcare professional as a subcutaneous injection, approximately 11 hours before the start of apheresis (stem cell collection), following an initial course of G-CSF. Your doctor will decide the dose and duration of use based on your body weight, condition, and treatment plan. It should never be self-administered without medical supervision.

Diarrhea, nausea, and injection site reactions are among the most common effects of this medicine. Your doctor may advise regular blood tests to monitor your white blood cell and platelet counts during treatment. Inform your doctor immediately if you notice difficulty breathing, swelling of the face or throat, severe abdominal pain, or unusual bleeding.

Uses Of Mozobil 24mg Injection:

  • Stem cell mobilization in Non-Hodgkin’s Lymphoma
  • Stem cell mobilization in Multiple Myeloma

Benefits Of Mozobil 24mg Injection:

1. Non-Hodgkin’s Lymphoma

In patients with non-Hodgkin’s lymphoma preparing for autologous stem cell transplantation, Mozobil 24mg Injection helps mobilize a sufficient number of stem cells from the bone marrow into the blood, supporting successful collection and later engraftment after transplant.

2. Multiple Myeloma

Multiple myeloma is a cancer of plasma cells in the bone marrow. Mozobil 24mg Injection, used together with G-CSF, helps improve the number of stem cells collected for transplantation, supporting better outcomes during the transplant process.

Side effects of Mozobil 24mg Injection:

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Common side effects of Mozobil:

  • Diarrhea
  • Nausea
  • Vomiting
  • Constipation
  • Dry mouth
  • Injection site reactions
  • Dizziness
  • Fatigue

Machanism Of Action Of Mozobil 24mg Injection:

Mozobil Injection contains Plerixafor, a CXCR4 chemokine receptor antagonist. It works by blocking the CXCR4 receptor on stem cells, which normally helps keep them anchored within the bone marrow. By interrupting this signal, Mozobil allows stem cells to be released into the bloodstream, where they can be collected for transplantation.
Contact Us

Reviews

There are no reviews yet.

Be the first to review “Mozobil Plerixafor 24mg Injection”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Mozobil 24mg Injection used for?
Mozobil 24mg Injection (Plerixafor) is a hematopoietic stem cell mobilizer used in autologous stem cell transplantation for patients with certain cancers.
It helps move stem cells from the bone marrow into the bloodstream, where they can be collected for transplantation after chemotherapy or radiation therapy.
It’s given as an injection by a qualified healthcare professional, with the dose based on your condition and treatment plan.
It’s a procedure where a patient’s own blood-forming stem cells are collected, and later returned to the body after chemotherapy or radiation treatment for certain cancers.
It’s manufactured by Genzyme, supplied as a 24mg vial, made in India.
It works by blocking a receptor that keeps stem cells anchored in the bone marrow, releasing them into the bloodstream so they can be collected for stem cell transplant procedures. See Drugs.com for more.

Related products